Sotagliflozin attenuates cardiac dysfunction and remodeling in myocardial infarction rats

OBJECTIVE: Sotagliflozin is a dual sodium-glucose co-transporter-1 and 2 (SGLT1/2) inhibitor with selectivity towards SGLT2. Previous studies showed that SGLT2 inhibitors can improve cardiac function and reduce myocardial infarction size in animal models of myocardial infarction (MI). However, it re...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Peng, Zhang, Jingjing, Wei, Yanzhao, Liu, Tao, Chen, Minxiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696107/
http://dx.doi.org/10.1016/j.heliyon.2023.e22423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696107/
http://dx.doi.org/10.1016/j.heliyon.2023.e22423

Ejemplares similares